Strides Pharma receives USFDA nod for two key ANDAs

Drug Discovery |  News | 0 Comment | 22 Aug, 2018

India's Strides Pharma  has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received ANDA “acceptable for filing” corre...Read more

GIC receives govt funding for immuno-oncology project

Drug Discovery |  News | 0 Comment | 22 Aug, 2018

Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related...Read more

Roche's Alecensa receives 'priority review' designation from CNDA

Drug Discovery |  News | 0 Comment | 21 Aug, 2018

Roche  recently announced that the China National Drug Administration (CNDA) has granted marketing authorization for Alecensa (alectinib) as a monotherapy treatment for patients with a...Read more

HitGen collaborates with LG Chem

Drug Discovery |  News | 0 Comment | 20 Aug, 2018

HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest. In this collaboration, HitGen ...Read more

Blueberry Therapeutics raises £10M funding to develop nanomedicines

Drug Discovery |  News | 0 Comment | 16 Aug, 2018

Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, has successfully com...Read more

Multi- institutional alliance to develop anti-aging drugs

Drug Discovery |  News | 0 Comment | 16 Aug, 2018

The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial intelligence (AI) to discover and develop novel anti-aging therapeutics ...Read more

FDA approves Amicus' Galafold for Fabry disease

Drug Discovery |  News | 0 Comment | 13 Aug, 2018

Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indica...Read more

Pfizer's Innovative drug IBRANCE gets China approval

Drug Discovery |  News | 0 Comment | 08 Aug, 2018

Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbociclib) on July 31st, the first cyclin-dependent Kinase 4/6 (CDK4/6) inh...Read more

DotBio successfully raises $2.3 M in seed financing

Drug Discovery |  News | 0 Comment | 07 Aug, 2018

Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, has officially launched and has successfully rai...Read more

Medpacto inks deal with AstraZeneca

Drug Discovery |  News | 0 Comment | 02 Aug, 2018

MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto’s vactosertib (TEW-7197), a small molecule, oral inhibitor of ...Read more

Pfizer's Herceptin biosimilar approved in Europe

Drug Discovery |  News | 0 Comment | 31 Jul, 2018

Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cancer med Herceptin (trastuzumab). TRAZIMERA, a potential biosimilar to ...Read more

Nektar's back pain opioid gets approval for FDA review

Drug Discovery |  News | 0 Comment | 30 Jul, 2018

 Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NKTR-181 for the treatment of chronic low back pain in adult patients n...Read more

Agios receives nod for ivosidenib

Drug Discovery |  News | 0 Comment | 23 Jul, 2018

Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a sus...Read more

FDA approves Pfizer's biosimilar

Drug Discovery |  News | 0 Comment | 23 Jul, 2018

Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected to hit the market at a significant discount to its reference drug. Th...Read more

FDA approves first drug indicating treatment of smallpox

Drug Discovery |  News | 0 Comment | 16 Jul, 2018

 Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Or...Read more

Immatics, Genmab to develop bispecific cancer immunotherapies

Drug Discovery |  News | 0 Comment | 12 Jul, 2018

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, has entered into a research c...Read more

FDA grants 7-year orphan drug exclusivity to Eagle

Drug Discovery |  News | 0 Comment | 09 Jul, 2018

Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seven years of orphan drug exclusivity (ODE) in the U.S., for BENDEKA (be...Read more

FDA grants ODD to OBI Pharma's lead investigational drug candidate

Drug Discovery |  News | 0 Comment | 09 Jul, 2018

OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for OBI-3424 for the Treatment of ...Read more